We’ve noticed a trend in public/private alliances and an increase in translational research facilities being built at university medical school campuses. Specifically, we've written about these innovative research funding trends in this blog series:
Translational Research (i.e. basic science to clinical science) centers are opening across the country at top medical schools and universities. These facilities can be largely privately-funded through philanthropy (see Duke and the Coulter Translational Research Center); publicly-funded through the NIH, such the university centers in the CTSA program; or, adjunct to hospital facilities (like Penn Med's new lab facility), may leverage funding through treatment and care channels. Bringing new technology to market through university translational research means private funding sources (such as VC) are not required to invest in the earlier, riskier, stages of new drug and product development.